BACKGROUND: Although non-alcoholic fatty liver disease (NAFLD) has become more prevalent with the rapid increase of obesity worldwide, no specific treatment has been developed. Several studies have shown that wheatgrass extract Triticum aestivum (TA) improves lipid metabolism. In the present study, we evaluated the efficacy of GM-T (an ethanolic TA extract) in a murine NAFLD model. Mice were separated into 12 groups (n = 10): two groups of normal diet, choline-deficient diet (CDD) or high-fat diet (HFD) with vehicle, CCD or HFD with silymarin (400 mg kg −1 day −1 ), and CCD or HFD with GM-T (100, 200 or 400 mg kg −1 day −1 ). The study was performed for 8 weeks for the CDD groups and 12 weeks for the HFD groups.
RESULTS:In the CDD-fed mice, GM-T improved serum liver enzyme activities and liver inflammation score compared to vehicle. In the HFD-fed mice, GM-T improved blood lipid profiles, liver inflammation score, steatosis score and obesity compared to vehicle.
CONCLUSION:The present study demonstrated that GM-T effectively improved NAFLD in mice via a mechanism that improved insulin resistance and lipid metabolism, suggesting the possibility of a functional dietary supplement to improve liver health, overall metabolic syndrome and obesity.
RESULTS
Effects of GM-T on liver enzyme alteration in CDD-fed miceSerum liver enzyme activities were analyzed in CDD-fed mice. Serum AST, ALT, ALP and LDH levels were significantly higher in the CDD with vehicle group (the negative control) than in mice fed the normal diet. In the GM-T groups, AST levels were decreased by 5.5%, 17% and 26.9% in the 100-mg kg −1 day −1 group, the 200-mg kg −1 day −1 group and the 400-mg kg −1 day −1 group, respectively, compared to the CDD with vehicle group; these effects were dose-dependent, although this finding did not reach statistical significance. ALT levels were significantly decreased by 27.5%, 51.5% and 36.1% in the 100-mg kg −1 day −1 group, the 200-mg kg −1 day −1 group and the 400-mg kg −1 day −1 group, respectively, compared to the CDD with vehicle group. LDH levels also were significantly decreased by 36%, 40.5% and 46.7% in the 100-mg kg −1 day −1 group, the 200-mg kg −1 day −1 group and the 400-mg kg −1 day −1 group, respectively, compared to the CDD with vehicle group. However, the ALP levels did not differ significantly between the GM-T and the CDD with vehicle groups. The CDD with silymarin group (the positive control) did not show any improvement in serum liver enzyme activities (Table 1).
Effects of GM-T on liver tissue in CDD-fed miceThe liver tissue samples of the CDD groups showed severe steatosis symptoms, such as macrovesicular and microvesicular fatty J Sci Food Agric